Status:
COMPLETED
A Comparison of Dexmedetomidine Versus Propofol for Use in Intravenous Sedation
Lead Sponsor:
Montefiore Medical Center
Conditions:
Anesthesia
Eligibility:
All Genders
18-35 years
Phase:
PHASE4
Brief Summary
Hypothesis: A combination of midazolam with dexmedetomidine for sedation during third molar surgery will provide 1) superior patient satisfaction, 2) superior operator satisfaction and 3) no significa...
Detailed Description
Intravenous sedation (IVS) is an integral aspect of the oral and maxillofacial surgeon's practice. For many minor oral surgical procedures, intravenous sedation is often necessary to manage patient an...
Eligibility Criteria
Inclusion
- Subject must have 3-4 partial or full bony impacted third molars requiring surgical extraction
- ASA Class I or II
- English-speaking and Spanish-speaking subjects
Exclusion
- ASA Class III or higher
- Patients taking alpha-2 agonists or benzodiazepines
- Allergy or drug reaction to any of the drugs used in this study (benzodiazepines, opioids, propofol, alpha-2 agonists, NSAIDs, local anesthetic)
- BMI greater than 30
- History of or current substance abuse or alcoholism
- History of mood-altering medications, tranquilizers, or antidepressants.
- Pregnant females
Key Trial Info
Start Date :
March 20 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 27 2019
Estimated Enrollment :
144 Patients enrolled
Trial Details
Trial ID
NCT03255824
Start Date
March 20 2018
End Date
December 27 2019
Last Update
May 13 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Montefiore Medical Center
The Bronx, New York, United States, 10461